Clinical Trial Update: Breast Cancer Evolution During Neoadjuvant Systemic Therapy

View source ↗

Summary

Update on a breast cancer neoadjuvant systemic therapy trial, currently recruiting and covering ER-positive, HER2-positive, and triple-negative breast cancer su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Breast Cancer, Triple Negative Breast Cancer | Status: RECRUITING